Total Funding
95
67
Total FundingPost-IPO Debt raised
Growth Score
-3 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
27584
ClearPoint Neuro is a platform neuro company that enables therapy for neuro disorders with pinpoint accuracy.
- Joseph Burnett: President and CEO
Peter G. Piferi: Chief Operating OfficerPast Role: Edwards Lifesciences, Vice President, Endovascular Technologies
About the Company
ClearPoint Neuro formerly known as MRI Interventions, is a platform neuro company. Its mission is to improve and restore the quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy.
Applications of ClearPoint Neuro's current product portfolio include deep-brain
stimulation, and biopsy, with future applications of laser ablation, neuro-aspiration, and delivery of drugs, biologics and gene therapy to the brain.
